Deczone-S 250mg/125mg Injection
Marketer
Daksh Pharma Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Deczone-S 250mg/125mg Injection
Deczone-S Injection (250mg/125mg) combines medications to combat diverse bacterial infections. Its action inhibits microbial proliferation, curbing infection spread. Administration must always be overseen by a doctor. Complete the prescribed regimen; premature cessation may compromise effectiveness. Regularly scheduled doses are crucial. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening symptoms immediately. Seek immediate medical attention for allergic reactions (skin rashes, itching, swelling, respiratory distress). Inform your physician of all other medications before starting Deczone-S, especially if pregnant or breastfeeding. Alcohol should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if experiencing dizziness or somnolence. Adequate rest, proper nutrition, and hydration will aid recovery. Your physician may order tests to monitor the medicine's effects.
Uses of Deczone-S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Deczone-S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Deczone-S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Deczone-S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Deczone-S 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Deczone-S 250mg/125mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to proliferate. The addition of Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, optimizing Ceftriaxone's efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Deczone-S 250mg/125mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Deczone-S (250mg/125mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; however, data from human clinical trials are currently insufficient.
Breast feedingCAUTION
The administration of Deczone-S 250mg/125mg Injection necessitates careful consideration during lactation. Mothers should discontinue breastfeeding for the duration of their treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
The administration of Deczone-S 250mg/125mg Injection can induce drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Deczone-S 250mg/125mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable formulation of Deczone-S (250mg/125mg) requires careful administration in individuals with advanced hepatic impairment; dosage modification may be necessary. Patients should seek medical advice. Altering the Deczone-S (250mg/125mg) injection dosage is generally unnecessary for those experiencing mild or moderate liver dysfunction.
What if you forget to take Deczone-S 250mg/125mg Injection :
Omit a Deczone-S 250mg/125mg Injection dose? Seek your physician's advice.
Facts to Know About Deczone-S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently